Market Value2,227,158,000
Total Holdings60
File Date2021-11-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
DSGN / Design Therapeutics, Inc.
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
TARS / Tarsus Pharmaceuticals, Inc.
GTH / Genetron Holdings Limited - Depositary Receipt (Common Stock)
KALV / KalVista Pharmaceuticals, Inc.
ELEV / Elevation Oncology, Inc.
INRLF / Valneva SE
CYTK / Cytokinetics, Incorporated
AADI / Aadi Bioscience, Inc.
SERA / Sera Prognostics, Inc.
VRDN / Viridian Therapeutics, Inc.
COGT / Cogent Biosciences, Inc.
ACRS / Aclaris Therapeutics, Inc.
DYN / Dyne Therapeutics, Inc.
ARQT / Arcutis Biotherapeutics, Inc.
OLMA / Olema Pharmaceuticals, Inc.
ZYME / Zymeworks Inc.
STSA / Satsuma Pharmaceuticals Inc
BOLT / Bolt Biotherapeutics, Inc.
ALXO / ALX Oncology Holdings Inc.
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
ZGNX / Zogenix Inc
DICE / DICE Therapeutics Inc
SRRA / Sierra Oncology Inc
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
AVDL / Avadel Pharmaceuticals plc
MTCR / Metacrine Inc
TXG / 10x Genomics, Inc.
SVA / Sinovac Biotech, Ltd.
PASG / Passage Bio, Inc.
CLTEF / Clara Technologies Corp.
CDXS / Codexis, Inc.
TCDA / Tricida Inc
NKTX / Nkarta, Inc.
NFH / New Frontier Health Corporation - Class A
LRMR / Larimar Therapeutics, Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
CLDX / Celldex Therapeutics, Inc.
EPIX / ESSA Pharma Inc.
ARWR / Arrowhead Pharmaceuticals, Inc.
HRMY / Harmony Biosciences Holdings, Inc.
KDMN / Kadmon Holdings Inc
MRUS / Merus N.V.
ASLN / ASLAN Pharmaceuticals Limited - Depositary Receipt (Common Stock)
KDNY / Chinook Therapeutics Inc
CRIS / Curis, Inc.
GRCL / Gracell Biotechnologies Inc. - Depositary Receipt (Common Stock)
SNDX / Syndax Pharmaceuticals, Inc.
ISEE / IVERIC bio Inc
AUPH / Aurinia Pharmaceuticals Inc.
IMVT / Immunovant, Inc.
NVAX / Novavax, Inc.
IMPL / Impel Pharmaceuticals Inc.
EIGR / Eiger BioPharmaceuticals, Inc.
KURA / Kura Oncology, Inc.
DTIL / Precision BioSciences, Inc.
TIL / Instil Bio, Inc.
FIXX / Homology Medicines, Inc.
AMRS / Amyris Inc
TERN / Terns Pharmaceuticals, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
ALGS / Aligos Therapeutics, Inc.